Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.17 USD -8.59% Market Closed
Market Cap: 215.4m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Nektar Therapeutics
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nektar Therapeutics
Total Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Nektar Therapeutics
NASDAQ:NKTR
Total Liabilities
$263.6m
CAGR 3-Years
-17%
CAGR 5-Years
-13%
CAGR 10-Years
-6%
Johnson & Johnson
NYSE:JNJ
Total Liabilities
$108.1B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
7%
Bristol-Myers Squibb Co
NYSE:BMY
Total Liabilities
$76.5B
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
15%
Pfizer Inc
NYSE:PFE
Total Liabilities
$128.5B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
3%
Merck & Co Inc
NYSE:MRK
Total Liabilities
$73B
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Total Liabilities
$61.4B
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
14%

See Also

What is Nektar Therapeutics's Total Liabilities?
Total Liabilities
263.6m USD

Based on the financial report for Jun 30, 2024, Nektar Therapeutics's Total Liabilities amounts to 263.6m USD.

What is Nektar Therapeutics's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
-6%

Over the last year, the Total Liabilities growth was -11%. The average annual Total Liabilities growth rates for Nektar Therapeutics have been -17% over the past three years , -13% over the past five years , and -6% over the past ten years .

Back to Top